-
AGC completes acquisition of Malgrat Pharma Chemicals
biospectrumasia
March 04, 2019
The acquisition of MPC has allowed the AGC Group to obtain another manufacturing and sales base outside of Japan, following the acquisitions of two biopharmaceutical CDMO companies, Biomeva (2016) and CMC Biologics (2017)
-
Ipsen to buy rare disease firm Clementia for up to $1.31bn
pharmaphorum
February 26, 2019
France’s Ipsen has agreed to buy Canadian rare diseases biotech Clementia Pharmaceuticals in a deal worth up to $1.31 billion.
-
Merck agrees to acquire Immune Design for $300m
pharmaceutical-technology
February 26, 2019
Merck has reached an agreement to acquire all outstanding shares of US-based late-stage immunotherapy firm Immune Design in an all cash deal valued at approximately $300m, or $5.85 per share....
-
Roche to acquire gene therapy specialist Spark Therapeutics for $4.8bn
pharmaceutical-technology
February 26, 2019
Roche has signed a definitive merger agreement to acquire all outstanding shares of US-based gene therapy company Spark Therapeutics for $114.50 per share....
-
Bausch Health Acquires Eton’s M-100 Investigational Eye Drop
americanpharmaceuticalreview
February 20, 2019
Bausch Health Companies and Bausch + Lomb, its wholly owned subsidiary and a leading global eye health company, and Eton Pharmaceuticals announced a subsidiary of Bausch Health has acquired the U.S. rights to Eton Pharmaceuticals' EM-100.....
-
Lilly closes $8bn Loxo Oncology acquisition
pharmaceutical-technology
February 19, 2019
Eli Lilly has completed the acquisition of all outstanding shares of Loxo Oncology in a deal valued at approximately $8bn, boosting its oncology portfolio with precision medicines to potentially treat genomically defined cancers.
-
Bharat Biotech acquires Chiron Behring Vaccines
biospectrumasia
February 18, 2019
Bharat Biotech will acquire 100% equity stake in Chiron Behring Vaccines in an all cash transaction.
-
Johnson & Johnson to Acquire Auris Health
americanpharmaceuticalreview
February 15, 2019
Johnson & Johnson announced that Ethicon entered into a definitive agreement to acquire Auris Health for approximately $3.4 billion in cash....
-
Aurobindo acquires Apotex’s operations in five European countries
expressbpd
February 12, 2019
The company had inked a binding agreement on July 14, 2018
-
Hitachi to acquire apceth Biopharma
biospectrumasia
February 02, 2019
This acquisition is expected to close in April 2019